Kate Therapeutics Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Employees
-
48
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.13B
Kate Therapeutics General Information
Description
Operator of a patient-focused biotechnology company intended to develop adeno-associated virus-based gene therapies to treat genetically defined muscle diseases. The company's novel capsids provide superior muscle transduction and liver de-targeting, above and beyond naturally occurring serotypes currently in clinical trials, this enables complete tissue transduction at significantly lower viral doses, thus addressing one of the major headwinds facing muscle gene delivery, enabling Patients with superior muscle and heart transduction and liver de-targeting compared to the naturally occurring serotypes.
Contact Information
Website
www.katetherapeutics.comCorporate Office
- 10675 Sorrento Valley Road
- Suite 150
- San Diego, CA 92121
- United States
Corporate Office
- 10675 Sorrento Valley Road
- Suite 150
- San Diego, CA 92121
- United States
Kate Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 31-Oct-2024 | $1.13B | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series B1) | 07-Aug-2024 | Completed | Pre-Clinical Trials | |||
| 1. Early Stage VC (Series A) | 08-Jun-2023 | $51M | $51M | Completed | Pre-Clinical Trials |
Kate Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series A-1 | ||||||||
| Series A | 16,000,000 | $0.000010 | 8% | $1 | $1 | 1x | $1 | 22.88% |
Kate Therapeutics Comparisons
Industry
Financing
Details
Kate Therapeutics Competitors (3)
One of Kate Therapeutics’s 3 competitors is Tenaya Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Tenaya Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Verve Therapeutics | Formerly VC-backed | Boston, MA | ||||
| Vasa Therapeutics | Venture Capital-Backed | Encinitas, CA |
Kate Therapeutics Patents
Kate Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026050402-A1 | Liver de-targeted muscle tropic capsids | Pending | 29-Aug-2024 | ||
| WO-2026030244-A1 | Adeno-associated virus compositions for the treatment of limb girdle muscular dystrophy 2a | Pending | 30-Jul-2024 | ||
| US-20260275379-A1 | Adeno-associated virus compositions for the treatment of facioscapulohumeral muscular dystrophy | Pending | 29-Jul-2024 | ||
| WO-2026030242-A1 | Adeno-associated virus compositions for the treatment of facioscapulohumeral muscular dystrophy | Pending | 29-Jul-2024 | ||
| WO-2026011009-A1 | Compositions and methods for muscle disorders | Pending | 02-Jul-2024 | C12N15/113 |
Kate Therapeutics Signals
Kate Therapeutics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| UF Innovate Ventures | Accelerator/Incubator | Minority | ||
| Versant Ventures | Venture Capital | Minority | ||
| Westlake Village BioPartners | Venture Capital | Minority |
Kate Therapeutics FAQs
-
When was Kate Therapeutics founded?
Kate Therapeutics was founded in 2020.
-
Where is Kate Therapeutics headquartered?
Kate Therapeutics is headquartered in San Diego, CA.
-
What is the size of Kate Therapeutics?
Kate Therapeutics has 48 total employees.
-
What industry is Kate Therapeutics in?
Kate Therapeutics’s primary industry is Drug Discovery.
-
Is Kate Therapeutics a private or public company?
Kate Therapeutics is a Private company.
-
What is the current valuation of Kate Therapeutics?
The current valuation of Kate Therapeutics is .
-
What is Kate Therapeutics’s current revenue?
The current revenue for Kate Therapeutics is .
-
How much funding has Kate Therapeutics raised over time?
Kate Therapeutics has raised $72.8M.
-
Who are Kate Therapeutics’s investors?
UF Innovate Ventures, Versant Ventures, and Westlake Village BioPartners have invested in Kate Therapeutics.
-
Who are Kate Therapeutics’s competitors?
Tenaya Therapeutics, Verve Therapeutics, and Vasa Therapeutics are competitors of Kate Therapeutics.
-
When was Kate Therapeutics acquired?
Kate Therapeutics was acquired on 31-Oct-2024.
-
Who acquired Kate Therapeutics?
Kate Therapeutics was acquired by Novartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process